[ibd-display-video id=2531707 width=50 float=left autostart=true] IBD's proprietary RS Rating identifies technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the best stocks typically have an RS Rating of above 80 as they begin their biggest runs. See if AFLAC can continue to rebound and clear that threshold.
AFLAC has moved more than 5% past a 79.96 entry in a first-stage flat base , meaning it's now out of a proper buy zone. Look for the stock to create a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The company showed 2% EPS growth in its most recent report. Revenue rose -4%.
AFLAC holds the No. 4 rank among its peers in the Insurance-Accident & Healthcare industry group. CNO Financial ( CNO ) is the No. 1-ranked stock within the group.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.